Glooko and Dexcom Inc. (NSDQ:DXCM) said today that they’ve inked a pact to deliver data from all of Dexcom’s continuous glucose monitors into Glooko’s platform. The companies agreed to share the Dexcom CGM data in 2015; the new cloud-based deal doesn’t require proactive connection to the Glooko database to effect the data transmission, they said. “With this […]
Dexcom
Artificial pancreas: These companies are racing to make one
Medical device companies are close to achieving the holy grail of diabetes treatment: a combined glucose sensor, control algorithm and insulin infusion device that effectively acts as an “artificial pancreas.” We explain more in the newest video from editors at MassDevice’s sister publication Medical Design & Outsourcing. (And for a deeper dive, check out our recent […]
DexCom prices $350m debt offering
Dexcom Inc. (NSDQ:DXCM) yesterday priced a $350 million debt offering, adding $50 million to the private placement it expects to close May 12. The offering, of 0.75% convertible senior notes, mature in May 2022 and can be redeemed for DXCM stock in February of that year. San Diego-based DexCom said the conversion rate is about 10.1 […]
DexCom shares drop on Q1 miss
Shares in DexCom Inc. (NSDQ:DXCM) have fallen in after hours trading today after the diabetes-focused medical device maker missed expectations on Wall Street with its 1st quarter results. The San Diego, Calif.-based company posted losses of $41.7 million, or 49¢ per share, on sales of $142.3 million for the 3 months ended March 31, seeing losses […]
These big medtech names performed the best in early 2017
Fink Densford, Associate Editor and Chris Newmarker, Managing Editor This year so far has been an especially good one for medical device company stocks. More than four-fifths of the world’s 100 largest medical device companies saw their stock values increase during the first quarter of 2017 – about half enjoyed double-digit percentage increases, according to an analysis […]
Medtech stocks: the best and worst of Q1 2017
More than four-fifths of the 100 largest medical device companies in the world saw their stock prices increase during the first three months of 2017, according to a Medical Design & Outsourcing analysis of how the stocks of our Big 100 companies are faring. The situation suggests that even with the uncertainty around what the […]
CMS updates on criteria for Dexcom G5 coverage
Shares in DexCom Inc. (NSDQ:DXCM) jumped 9% today after the Centers for Medicare & Medicaid Services updated the criteria for coverage of the company’s G5 Mobile continuous glucose monitor. The device is the only therapeutic CGM classified as durable medical equipment under Medicare Part B. Patients covered by Medicare who have Type I or II diabetes and […]
DexCom beats Street with Q4 earnings
Shares in DexCom Inc. (NSDQ:DXCM) rose today after the medical device maker met expectations on Wall Street with its 4th quarter results. The San Diego-based company posted a loss of -$7.4 million, or -9¢ per share, on sales of $171.2 million for the 3 months ended Dec. 31, for bottom-line loss of -593.3% on sales growth […]
Baxter snags Medtronic vet Oesterle | Personnel Moves | February 14, 2017
Baxter (NYSE:BAX) announced earlier this month it tapped former Medtronic (NYSE:MDT) senior VP of medicine and tech Stephen Oesterle for its board of directors, bringing the total seats on the board to 12. Oesterle moved to the venture capital firm New Enterprise Associates last Sept from his position at Medtronic. Before moving to NEA, Oesterle served […]
Study: DexCom touts low A1C, more “in range” time for MDI patients using CGM
DexCom (NSDQ:DXCM) today announced the publication of study results from a trial examining the benefit of continuous glucose monitoring for diabetes patients on multiple daily injections, touting significant A1C reductions and more time “in range.” Results from the Diamond trial indicated a 1% average A1C reduction after 24 weeks of regular use compared to a baseline, as […]
Dexcom surges on Medicare nod for continuous glucose monitors
DexCom (NSDQ:DXCM) said yesterday that the Centers for Medicare & Medicaid classified therapeutic continuous glucose monitors as durable medical equipment under Medicare Part B. The company’s Dexcom G5 Mobile is the only CGM system that falls under this classification, according to San Diego, Calif.-based DexCom, since patients can make treatment decisions using the device. DXCM […]